{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:12:54Z","timestamp":1781208774409,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Mass Spectrometry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ijms.2020.116377","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T02:23:42Z","timestamp":1592015022000},"page":"116377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes, influenza and other viral infections"],"prefix":"10.1016","volume":"455","author":[{"given":"W.M.A.","family":"Niessen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijms.2020.116377_bib1","article-title":"Tandem mass spectrometry of small-molecule antiviral drugs: 1. HIV-related antivirals","author":"Niessen","year":"2020","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib2","article-title":"Tandem mass spectrometry of small-molecule antiviral drugs: 2. Hepatitis-related antivirals","author":"Niessen","year":"2020","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","article-title":"Antiviral therapies for herpesviruses: current agents and new directions","volume":"40","author":"Poole","year":"2018","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ijms.2020.116377_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijms.2020.116377_bib5","author":"Boktor"},{"key":"10.1016\/j.ijms.2020.116377_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2016.04.036","article-title":"Simultaneous determination of 14 antiviral drugs and relevant metabolites in chicken muscle by UPLC-MS\/MS after QuEChERS preparation","volume":"1023\u20131024","author":"Mu","year":"2016","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jssc.201401461","article-title":"Simultaneous determination of antiviral drugs in chicken tissues by ultra-high performance liquid chromatography with tandem mass spectrometry","volume":"38","author":"Liu","year":"2015","journal-title":"J.\u00a0Separ. Sci."},{"key":"10.1016\/j.ijms.2020.116377_bib8","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/jssc.201600490","article-title":"Chromatography column comparison and rapid pretreatment for the simultaneous analysis of amantadine, rimantadine, acyclovir, ribavirin, and moroxydine in chicken muscle by ultra-high performance liquid chromatography and tandem mass spectrometry","volume":"39","author":"Zhang","year":"2016","journal-title":"J.\u00a0Separ. Sci."},{"key":"10.1016\/j.ijms.2020.116377_bib9","author":"Agilent Technologies"},{"key":"10.1016\/j.ijms.2020.116377_bib10","series-title":"Interpretation of MS-MS Mass Spectra of Drugs and Pesticides","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1002\/9781119294269","author":"Niessen","year":"2017","ISBN":"https:\/\/id.crossref.org\/isbn\/9781118500187"},{"key":"10.1016\/j.ijms.2020.116377_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jms.124","article-title":"Solvation of acylium fragment ions in electrospray ionization quadrupole ion trap and Fourier transform ion cyclotron resonance mass spectrometry","volume":"36","author":"Guan","year":"2001","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/rcm.792","article-title":"Hydrophilic interaction liquid chromatography\/electrospray mass spectrometry determination of acyclovir in pregnant rat plasma and tissues","volume":"16","author":"Brown","year":"2002","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/bmc.1093","article-title":"Determination of acyclovir in horse plasma and body fluids by high-performance liquid chromatography combined with fluorescence detection and heated electrospray ionization tandem mass spectrometry","volume":"23","author":"Maes","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116377_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.clinbiochem.2011.04.003","article-title":"Determination of valganciclovir and ganciclovir in human plasma by liquid chromatography tandem mass spectrometric detection","volume":"44","author":"Singh","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijms.2020.116377_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jpba.2010.06.034","article-title":"Determination of cidofovir in human plasma after low dose drug administration using high-performance liquid chromatography-tandem mass spectrometry","volume":"53","author":"Momper","year":"2010","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116377_bib16","article-title":"Validation of an assay for quantifying ganciclovir in dried blood spots","volume":"184","author":"Rower","year":"2020","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116377_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jchromb.2006.10.053","article-title":"A\u00a0sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC\/MS\/MS","volume":"848","author":"Xu","year":"2007","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jasms.2007.05.001","article-title":"Collisionally-induced dissociation of substituted pyrimidine antiviral agents: mechanisms of ion formation using gas phase hydrogen\/deuterium exchange and electrospray ionization tandem mass spectrometry","volume":"18","author":"Kamel","year":"2007","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib19","first-page":"1234","article-title":"Development and validation of a LC-MS\/MS method for the determination of letermovir in sprague dawley rat plasma and its application to pharmacokinetic study","volume":"8","author":"Rajanikanth","year":"2019","journal-title":"WJPPA"},{"key":"10.1016\/j.ijms.2020.116377_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jchromb.2007.01.044","article-title":"Development and validation of a high-performance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: application to a bioequivalence study","volume":"852","author":"Lee","year":"2007","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bmc.1468","article-title":"Determination of penciclovir in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study","volume":"25","author":"Kanneti","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116377_bib22","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/AAC.02641-14","article-title":"Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model","volume":"58","author":"Biswas","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.11.002","article-title":"Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis","volume":"149","author":"Quenelle","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijms.2020.116377_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1570-0232(02)00379-3","article-title":"Specific, sensitive and accurate liquid chromatographic-tandem mass spectrometric method for the measurement of ribavirin in rat and monkey plasma","volume":"779","author":"Lin","year":"2002","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchromb.2015.08.038","article-title":"Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS\/MS","volume":"1002","author":"Shi","year":"2015","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jchromb.2009.01.042","article-title":"Stability evaluation and sensitive determination of antiviral drug, valacyclovir and its metabolite acyclovir in human plasma by a rapid liquid chromatography-tandem mass spectrometry method","volume":"877","author":"Yadav","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1255\/ejms.538","article-title":"Collision-induced dissociation of purine antiviral agents: mechanisms of ion formation using gas-phase Hydrogen\/Deuterium exchange and electrospray ionization tandem mass spectrometry","volume":"10","author":"Kamel","year":"2004","journal-title":"Eur. J. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib28","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/AAC.00118-06","article-title":"Absorption, metabolism, and excretion of [14C]viramidine in humans","volume":"50","author":"Lin","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10337-011-2001-y","article-title":"LC\u2013MS\u2013MS quantitative determination of brivudine in human plasma and its application to pharmacokinetic studies","volume":"73","author":"Peng","year":"2011","journal-title":"Chromatographia"},{"key":"10.1016\/j.ijms.2020.116377_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2007.11.029","article-title":"Quantification of cidofovir in human serum by LC-MS\/MS for children","volume":"861","author":"Breddemann","year":"2008","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1389557517666170216151601","article-title":"Amino acid ester prodrugs of nucleoside and nucleotide antivirals","volume":"17","author":"Kre\u010dmerov\u00e1","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ijms.2020.116377_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cccn.2005.03.040","article-title":"Determination of serum amantadine by liquid chromatography-tandem mass spectrometry","volume":"359","author":"Arndt","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijms.2020.116377_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jchromb.2014.06.038","article-title":"Simultaneous determination of amantadine, rimantadine and memantine in chicken muscle using multi-walled carbon nanotubes as a reversed-dispersive solid phase extraction sorbent","volume":"965","author":"Wu","year":"2014","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jchromb.2018.07.025","article-title":"Simultaneous determination of antibiotics and amantadines in animal-derived feedstuffs by ultraperformance liquid chromatographic-tandem mass spectrometry","volume":"1095","author":"Decheng","year":"2018","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0091270009356297","article-title":"Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers","volume":"50","author":"Ishizuka","year":"2010","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ijms.2020.116377_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2007.09.018","article-title":"Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine","volume":"859","author":"Lindeg\u00e5rdh","year":"2007","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2008.11.009","article-title":"Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma","volume":"1215","author":"Lindegardh","year":"2008","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ijms.2020.116377_bib38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13318-016-0390-x","article-title":"In\u00a0vitro evaluation of absorption characteristics of peramivir for oral delivery","volume":"42","author":"Li","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.ijms.2020.116377_bib39","article-title":"HPLC-MS\/MS analysis of peramivir in rat plasma: elimination of matrix effect using the phospholipid-removal solid-phase extraction method","volume":"32","author":"Lei","year":"2018","journal-title":"Biomed. Chromatogr. Mar."},{"key":"10.1016\/j.ijms.2020.116377_bib40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jchromb.2009.02.044","article-title":"Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography\/tandem mass spectrometry","volume":"877","author":"Li","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib41","first-page":"1100","article-title":"High-performance liquid chromatography\/tandem mass spectrometry method for the determination of arbidol in human plasma","volume":"94","author":"Xiong","year":"2011","journal-title":"J.\u00a0AOAC Int."},{"key":"10.1016\/j.ijms.2020.116377_bib42","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.02282-12","article-title":"Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans","volume":"57","author":"Deng","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0378-4347(99)00306-0","article-title":"Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum","volume":"732","author":"Allen","year":"1999","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jchromb.2007.02.006","article-title":"Determination of zanamivir in rat and monkey plasma by positive ion hydrophilic interaction chromatography (HILIC)\/tandem mass spectrometry","volume":"852","author":"Baughman","year":"2007","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.talanta.2015.03.066","article-title":"Online solid phase extraction liquid chromatography using bonded zwitterionic stationary phases and tandem mass spectrometry for rapid environmental trace analysis of highly polar hydrophilic compounds - application for the antiviral drug Zanamivir","volume":"141","author":"Lindberg","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.ijms.2020.116377_bib46","article-title":"Analysis of amantadine in Laminaria Japonica and seawater of Daqin Island by ultra-high performance liquid chromatography with positive electrospray ionization tandem mass spectrometry","volume":"1126\u20131127","author":"Xu","year":"2019","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhazmat.2013.10.008","article-title":"Evaluation of the phototransformation of the antiviral zanamivir in surface waters through identification of transformation products","volume":"265","author":"Zonja","year":"2014","journal-title":"J.\u00a0Hazard Mater."},{"key":"10.1016\/j.ijms.2020.116377_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpba.2012.01.001","article-title":"ICH guidance in practice: degradation behaviour of oseltamivir phosphate under stress conditions","volume":"62","author":"Junwal","year":"2012","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116377_bib49","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jms.1394","article-title":"Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry","volume":"43","author":"Wang","year":"2008","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/187152607780090757","article-title":"Antiviral strategies against human coronaviruses","volume":"7","author":"Pyrc","year":"2007","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.ijms.2020.116377_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ijms.2020.116377_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/095632020501600102","article-title":"New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus","volume":"16","author":"Oxford","year":"2005","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/13543770802609384","article-title":"Therapies for coronaviruses. Part I of II -- viral entry inhibitors","volume":"19","author":"Tong","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijms.2020.116377_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/13543770802600698","article-title":"Therapies for coronaviruses. Part 2: inhibitors of intracellular life cycle","volume":"19","author":"Tong","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijms.2020.116377_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijms.2020.116377_bib56","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/jmm.0.000565","article-title":"A\u00a0review of candidate therapies for Middle East respiratory syndrome from a molecular perspective","volume":"66","author":"Rabaan","year":"2017","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ijms.2020.116377_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","volume":"64","author":"Martinez","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib58","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ijms.2020.116377_bib59","first-page":"416","article-title":"Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019","volume":"40","author":"Barlow","year":"2020","journal-title":"Pharma"},{"key":"10.1016\/j.ijms.2020.116377_bib60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijms.2020.116377_bib61","doi-asserted-by":"crossref","first-page":"m1432","DOI":"10.1136\/bmj.m1432","article-title":"Chloroquine and hydroxychloroquine in covid-19","volume":"369","author":"Ferner","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijms.2020.116377_bib62","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpba.2009.02.003","article-title":"A\u00a0sensitive method for the determination of entecavir at picogram per milliliter level in human plasma by solid phase extraction and high-pH LC-MS\/MS","volume":"49","author":"Zhang","year":"2009","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116377_bib63","article-title":"A\u00a0new sensitive method for the simultaneous chromatographic separation and tandem mass spectrometry detection of anticoccidials, including highly polar compounds, in environmental waters","volume":"460857","author":"Mooney","year":"2020","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ijms.2020.116377_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0091270005283286","article-title":"The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe","volume":"46","author":"Ma","year":"2006","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ijms.2020.116377_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkaa152","article-title":"Development and validation of a UHPLC-MS\/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2\/COVID-19 and Ebola virus disease","volume":"75","author":"Avataneo","year":"2020","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jchromb.2008.09.011","article-title":"Simultaneous quantification of tiloronoxim and tilorone in human urine by liquid chromatography-tandem mass spectrometry","volume":"875","author":"Zhang","year":"2008","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jchromb.2009.12.016","article-title":"Performance of tiloronoxim and tilorone determination in human blood by HPLC-MS\/MS: method validation, uncertainty assessment and its application to a pharmacokinetic study","volume":"878","author":"Zhang","year":"2010","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116377_bib68","article-title":"Clinical regimens of favipiravir inhibit zika virus replication in the hollow-fiber infection model","volume":"62","author":"Pires de Mello","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijms.2020.116377_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5806\/AST.2011.24.2.078","article-title":"Electrospray ionization tandem mass fragmentation pattern of camostat and its degradation product, 4-(4-guanidinobenzoyloxy)phenylacetic acid","volume":"24","author":"Kwon","year":"2011","journal-title":"Anal. Sci. Technol."},{"key":"10.1016\/j.ijms.2020.116377_bib70","article-title":"Identification of impurities in nafamostat mesylate using HPLC-IT-TOF\/MS: a series of double-charged ions","volume":"10","author":"Zhang","year":"2020","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.ijms.2020.116377_bib71","series-title":"Mass Spectrometry","isbn-type":"print","first-page":"133","article-title":"Chemical ionization mass spectrometry","author":"Field","year":"1972","ISBN":"https:\/\/id.crossref.org\/isbn\/9780408702669"},{"key":"10.1016\/j.ijms.2020.116377_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/oms.1210150303","article-title":"Unimolecular decompositions of even-electron ions","volume":"15","author":"McLafferty","year":"1980","journal-title":"Org. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/oms.1210150202","article-title":"The \u2018even-electron\u2019 rule","volume":"15","author":"Karni","year":"1980","journal-title":"Org. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116377_bib74","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jms.1234","article-title":"Even-electron ions: a systematic study of the neutral species lost in the dissociation of quasi-molecular ions","volume":"42","author":"Levsen","year":"2007","journal-title":"J.\u00a0Mass Spectrom."}],"container-title":["International Journal of Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138738062030169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138738062030169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:34:57Z","timestamp":1761377697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138738062030169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":74,"alternative-id":["S138738062030169X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijms.2020.116377","relation":{},"ISSN":["1387-3806"],"issn-type":[{"value":"1387-3806","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes, influenza and other viral infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Mass Spectrometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijms.2020.116377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116377"}}